Global Active Pharmaceutical Ingredients Market to Surpass US$ 284.3 Billion by 2027, Says Coherent Market Insights (CMI)

SEATTLE–(BUSINESS WIRE)–#APIs–According to Coherent Market Insights, the global active pharmaceutical ingredients market is estimated to be valued at US$ 180.4 billion in 2020 and is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Active Pharmaceutical Ingredients Market:

Key trends in the market include the growing prevalence of chronic diseases such as cardiac diseases, respiratory diseases, etc., and geographic expansion of API manufacturers in Asia. According to the World Health Organization, non-communicable disease fact sheet 2017, non-communicable diseases account for 70% of all deaths globally. Each year, 15 million people die from a non-communicable disease between the age group of 30 and 69 years, and over 80% of premature deaths occur in low- and average-income countries.

Furthermore, demand for high potency active pharmaceutical ingredients (HPAPIs) is increasing due to high potency API ability to target diseased cells more precisely and selectively than other APIs and is regarded as a relatively more efficient treatment for cancer and chronic diseases such as diabetes and heart diseases, worldwide.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/738

Key Market Takeaways:

The global active pharmaceutical ingredients market is expected to exhibit a CAGR of 6.7% during the forecast period due to the growing production capacities of Asia-based API manufacturers, and rising incidence of chronic diseases. For instance, in April 2018, STA Pharmaceutical, a subsidiary of WuXi AppTec signed an investment agreement with the government of Shanghai to build a new research & development (R&D) center for APIs and intermediates located next to the company’s existing Jinshan drug-substance manufacturing site. The company will add more than 30,000 square meters of laboratory space and 500 scientists. (Read more…)

Among product type, the low potent APIs segment is estimated to hold a dominant position in the global active pharmaceutical ingredients market in 2020 owing to less technical hindrance for low potent APIs, rising R&D expenses by biopharmaceutical companies, and increasing number of CDMOs. According to an article published by Pharma Manufacturing (part of Putman Media, Inc.), Pharma R&D spending increased by 5% in 2019, and among the top 11 pharma companies summed a total of U$ 77.6 billion.

North America is estimated to hold the largest market share in the global active pharmaceutical ingredients market in 2020 due to higher consumption of APIs for manufacturing finished dosage forms in the biopharmaceutical industry in North America. For instance, as per the US FDA Center for Drug Evaluation and Research, 510 API manufacturing facilities for all drugs manufactured in the U.S. were based in the U.S.

Competitive Landscape:

Key players operating in the global active pharmaceutical ingredients market are Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Endo International plc, Dr. Reddy’s Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Stada Arzneimittel AG, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Aurobindo Pharma Limited, Apotex Inc., Cipla Limited, Taro Pharmaceutical Industries Ltd., Biological E. Limited, CordenPharma International, Evonik Industries AG, Sun Pharmaceutical Industries Ltd., Glenmark Pharma, and Krka Pharmaceuticals.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/738

Market Segmentation:

• Global Active Pharmaceutical Ingredients Market, By Product Type:
  • High Potent APIs
  • Low Potent APIs
• Global Active Pharmaceutical Ingredients Market, By Molecule Type:
  • Small Molecules
  • Large Molecules
• Global Active Pharmaceutical Ingredients Market, By Formulation:
  • Oral
  • Topical
  • Injectables
  • Drops
• Global Active Pharmaceutical Ingredients Market, By Application:
  • Diabetes
  • Oncology
  • Cardiovascular
  • CNS
  • Analgesics
  • Ophthalmic
  • Respiratory
  • Dermatology
  • Others
• Global Active Pharmaceutical Ingredients Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: [email protected]
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter